An automated and fully validated LC-MS/MS procedure for the simultaneous determination of 11 opioids used in palliative care, with 5 of their metabolites.
A fully validated liquid chromatographic procedure coupled with electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) is presented for quantitative determination of the opioids buprenorphine, codeine, fentanyl, hydromorphone, methadone, morphine, oxycodone, oxymorphone, piritramide, tilidine, and tramadol together with their metabolites bisnortilidine, morphine-glucuronides, norfentanyl, and nortilidine in blood plasma after an automatically performed solid-phase extraction (SPE). Separation was achieved in 35 min on a Phenomenex C12 MAX-RP column (4 microm, 150 x 2 mm) using a gradient of ammonium formiate buffer (pH 3.5) and acetonitrile. The validation data were within the required limits. The assay was successfully applied to authentic plasma samples, allowing confirmation of the diagnosis of overdose situations as well as monitoring of patients' compliance, especially in patients under palliative care.
Musshoff
F
F
Institute of Forensic Medicine, Stiftsplatz 12, 53111 Bonn, Germany. f.musshoff@uni-bonn.de
Trafkowski
J
J
Kuepper
U
U
Madea
B
B
D000701:Analgesics, Opioid / Q000032:analysis / Q000097:blood* / Q000493:pharmacokinetics*; D002853:Chromatography, Liquid / Q000379:methods* / Q000592:standards; D005283:Fentanyl / Q000031:analogs & derivatives / Q000032:analysis / Q000097:blood; D006801:Humans; D009022:Morphine Derivatives / Q000032:analysis / Q000097:blood; D010166:Palliative Care; D010349:Patient Compliance; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods* / Q000592:standards; D013993:Tilidine / Q000031:analogs & derivatives / Q000032:analysis / Q000097:blood
D000701:Analgesics, Opioid; D009022:Morphine Derivatives; C080127:norfentanyl; C062492:bisnortilidine; C035349:morphine-6-glucuronide; C062490:nortilidine; D013993:Tilidine; C018108:morphine-3-glucuronide; D005283:Fentanyl